Lv1
4 积分 2025-08-19 加入
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
17小时前
已完结
Microglia prune developing cortical blood vessels through PD-1 signaling
1天前
已完结
Spatial distribution of the proteome in the human body and in cancers
1天前
已完结
Sphingosine-1-Phosphate-derived 2-Hexadecenal is a central mediator of ocular neovascularization by inhibiting Sphingosine-1-Phosphate receptor 5
1天前
已完结
Structure-based design of non-hypertrophic apelin receptor modulator
2天前
已完结
Clinical application of base editing for treating β-thalassaemia
4天前
已完结
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease
5天前
已完结
Targeting NK cell CLEC12B enhances cancer immunotherapy
5天前
已完结
Targeting NK cell CLEC12B enhances cancer immunotherapy
6天前
已完结
Lonvoguran Ziclumeran — In Vivo CRISPR Gene Editing in Hereditary Angioedema
6天前
已完结
皖公网安备34019202002308
